TAMPA, Fla., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, announced today that SRx Health Solutions, Inc. (“SRx”) held its special meeting of shareholders whereby approximately 93% voted in favor of the acquisition by the Company.

Lincoln Educational Services Corporation (NASDAQ:LINC ) Q4 2024 Earnings Conference Call February 24, 2025 10:00 AM ET Company Participants Michael Polyviou - Investor Relations Scott Shaw - President & Chief Executive Officer Brian Meyers - Chief Financial Officer Conference Call Participants Alex Paris - Barrington Research Steven Frankel - Rosenblatt Securities Eric Martinuzzi - Lake Street Operator Good day, and thank you for standing by. Welcome to the Q4 2024 Lincoln Educational Services Earnings Conference Call.

GT's transformation efforts show promise, but inflation and fierce competition pose significant challenges.

Berkshire on Saturday said fourth-quarter profit from its 189 operating businesses rose 71% to $14.53 billion.

Database company MongoDB acquired artificial intelligence firm Voyage AI. The deal — worth $220 million, according to a Monday (Feb. 24) Bloomberg report — is designed to help MongoDB's customers build better AI-powered applications through “highly accurate and relevant information retrieval deeply integrated with operational data,” according to a Monday press release.

The Franklin U.S. Low Volatility High Dividend ETF has a portfolio of 111 stocks selected based on yield, price volatility and earnings volatility. LVHD has value characteristics and a focus on utilities and consumer staples. LVHD has lagged the Russell 3000 and a number of competitors in the low-volatility and dividend ETF categories.

While INVH's Q4 results are likely to reflect gains from solid demand for single-family rental units and an asset-light model, high unit supply might have hurt.

BioMarin (BMRN) possesses solid growth attributes, which could help it handily outperform the market.

SM Energy (SM) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Insteel Industries (IIIN) is well positioned to outperform the market, as it exhibits above-average growth in financials.

The AZEK Company (AZEK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Halozyme Therapeutics (HALO) possesses solid growth attributes, which could help it handily outperform the market.

Patria Investments (PAX) could produce exceptional returns because of its solid growth attributes.

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=131839&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your Monolithic Power Systems Inc. (NASDAQ:MPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/monolithic-lawsuit-submission-form?prid=131840&wire=1 or contact Joseph E. Levi, Esq.

J.P. Morgan has upgraded Amneal Pharmaceuticals, Inc AMRX, noting the company's generics business is increasingly well-positioned with a solid Crexont launch and continued momentum across the portfolio.

Starbucks announced on Monday it would be laying off 1,100 corporate employees. The coffee chain also said it would be removing 13 menu items on March 4.

Monro Q3 Earnings: Too Early To Call A Turnaround

Shares of Constellation Energy Corporation (CEG) are trading lower Monday. This comes after Friday's sell off of more than 8%.

Howmet Aerospace reported strong earnings growth, with Q4 sales up 9% and EBITDA increasing 27%, driven by robust demand in commercial aerospace and defense segments. The company is well-positioned for future growth, with a 2025 sales guidance of 8% and EBITDA growth of 11%, supported by higher commercial airplane production. Despite appearing expensive, Howmet Aerospace's strong financial health, low debt, and focus on shareholder returns make it a compelling buy.